Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type-1 receptorsMuneer Ahamed, Alfons Verbruggen, Guy BormansMethods (San Diego, Calif.)|March 26, 2009
Developing new molecular imaging probes for PETKim Serdons, Alfons Verbruggen, Guy M BormansEuropean Journal of Nuclear Medicine and Molecular Imaging|March 6, 2012
Feasibility and availability of ⁶⁸Ga-labelled peptidesClemens Decristoforo, Roger D Pickett, Alfons VerbruggenJournal of Cancer|February 16, 2013
Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer ApplicationsJunjie Li, Raymond Oyen, Alfons Verbruggen, et al.Current Pharmaceutical Design|June 19, 2014
PET radioligands for in vivo visualization of neuroinflammationDieter Ory, Sofie Celen, Alfons Verbruggen, et al.Investigative Radiology|July 19, 2005
Necrosis avid contrast agents: functional similarity versus structural diversityYicheng Ni, Guy Bormans, Feng Chen, et al.World Journal of Methodology|September 20, 2014
An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applicationsMarlein Miranda Cona, Peter de Witte, Alfons Verbruggen, et al.Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Characterisation and biodistribution of two neutral 99mTc(CO)3 complexes with a tridentate ligandDirk Rattat, Bernard Cleynhens, Guy Bormans, et al.Bioorganic & Medicinal Chemistry|November 21, 2009
99mTc-tricarbonyl labeled agents for cell labeling: development, biodistribution in normal mice and preliminary in vitro evaluationHumphrey Fonge, Lixin Jin, Jan Cleynhens, et al.Nuclear Medicine Communications|June 1, 2010
Optimal buffer choice of the radiosynthesis of (68)Ga-Dotatoc for clinical applicationMatthias Bauwens, Rufael Chekol, Hubert Vanbilloen, et al.Pageof 10